Zobrazeno 1 - 10
of 12
pro vyhledávání: '"35"'
Autor:
Sylke Nagel, Aruna Raghavachar, Ludwig Fischer von Weikersthal, Monika Serke, Ernst-Wilhelm Schmidt, Christine Lautenschlaeger, Hans Schweisfurth, Wolfgang Schuette, Ina Dittrich, Klaus Hans, Thomas Blankenburg, Angelika Reißig
Publikováno v:
Journal of Clinical Oncology. 23:8389-8395
Purpose A phase III study to determine whether a weekly docetaxel schedule improves the therapeutic index compared with the classic 3-weekly schedule. Patients and Methods Patients with stage IIIB-IV non–small-cell lung cancer (NSCLC) were randomly
Autor:
Christopher Sweeney, Eric Winquist, Darren R. Feldman, Ugo De Giorgi, Daniel Y.C. Heng, Silke Gillessen, Michal Chovanec, Jourik A. Gietema, Robert Huddart, Costantine Albany, Fay H. Cafferty, Peter Grimison, Aaron R. Hansen, Carsten Bokemeyer, Karim Fizazi, Jörg Beyer, Christian D. Fankhauser, Nicolas Sauvé, Alexey Tryakin, Torgrim Tandstad, Olof Ståhl, Helene F. S. Negaard, Ronald de Wit, Anja Lorch, Andrea Necchi, David J. Vaughn, Angelika Terbuch, Axel Heidenreich, Cora N. Sternberg, Marcus Hentrich, Xavier Garcia-del-Muro, Gedske Daugaard, Laurence Collette, Jonathan Shamash
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
J Clin Oncol
Gillessen, Silke; Sauvé, Nicolas; Collette, Laurence; Daugaard, Gedske; de Wit, Ronald; Albany, Costantine; Tryakin, Alexey; Fizazi, Karim; Stahl, Olof; Gietema, Jourik A; De Giorgi, Ugo; Cafferty, Fay H; Hansen, Aaron R; Tandstad, Torgrim; Huddart, Robert A; Necchi, Andrea; Sweeney, Christopher J; Garcia-Del-Muro, Xavier; Heng, Daniel Y C; Lorch, Anja; ... (2021). Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 39(14), pp. 1563-1574. 10.1200/JCO.20.03296
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 39(14), 1563-+. AMER SOC CLINICAL ONCOLOGY
Universidad de Barcelona
J Clin Oncol
Gillessen, Silke; Sauvé, Nicolas; Collette, Laurence; Daugaard, Gedske; de Wit, Ronald; Albany, Costantine; Tryakin, Alexey; Fizazi, Karim; Stahl, Olof; Gietema, Jourik A; De Giorgi, Ugo; Cafferty, Fay H; Hansen, Aaron R; Tandstad, Torgrim; Huddart, Robert A; Necchi, Andrea; Sweeney, Christopher J; Garcia-Del-Muro, Xavier; Heng, Daniel Y C; Lorch, Anja; ... (2021). Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 39(14), pp. 1563-1574. 10.1200/JCO.20.03296
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 39(14), 1563-+. AMER SOC CLINICAL ONCOLOGY
PURPOSE The classification of the International Germ Cell Cancer Collaborative Group (IGCCCG) plays a pivotal role in the management of metastatic germ cell tumors but relies on data of patients treated between 1975 and 1990. MATERIALS AND METHODS Da
Autor:
John C. Ruckdeschel, P. Bonomi, Antonio C. Wolff, Donna Neuberg, David H. Johnson, David S. Ettinger, Robert L. Comis
Publikováno v:
Journal of Clinical Oncology. 13:1615-1622
PURPOSE A phase II study of ifosfamide, carboplatin, and prolonged oral administration of etoposide (ICE) in patients with untreated extensive-disease (ED) small-cell lung cancer (SCLC) was conducted to assess toxicities, response, and median surviva
Autor:
Yenting Ngai, Julian Singer, Mark Napier, Abhro Chaudhuri, Rachel Lillywhite, Michael Gandy, Robin M. Rudd, Fiona H Blackhall, Samreen Ahmed, David Ferry, Allan Hackshaw, Marianne Nicolson, Arrigo Capitanio, Gary Middleton, Natasha Iles, Siow Ming Lee, Mary Falzon, B. Crosse, James Spicer, Martin Forster, Sally-Ann Rolls, J. Hicks, Conrad R. Lewanski
Publikováno v:
Lee, S M, Falzon, M, Blackhall, F, Spicer, J, Nicolson, M, Chaudhuri, A, Middleton, G, Ahmed, S, Hicks, J, Crosse, B, Napier, M, Singer, J M, Ferry, D, Lewanski, C, Forster, M, Rolls, S-A, Capitanio, A, Rudd, R, Iles, N, Ngai, Y, Gandy, M, Lillywhite, R & Hackshaw, A 2017, ' Randomized Prospective Biomarker Trial of ERCC1 for Comparing Platinum and Nonplatinum Therapy in Advanced Non-Small-Cell Lung Cancer : ERCC1 Trial (ET) ', Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 35, no. 4, pp. 402-411 . https://doi.org/10.1200/JCO.2016.68.1841
Purpose Retrospective studies indicate that expression of excision repair cross complementing group 1 (ERCC1) protein is associated with platinum resistance and survival in non–small-cell lung cancer (NSCLC). We conducted the first randomized trial
Autor:
Frank V. Fossella, Roy S. Herbst, Rebecca Paulus, Walter J. Curran, Hak Choy, Philip O. Doescher, George R. Blumenschein, Ritsuko Komaki, Maria Werner-Wasik, Francisco Robert
Publikováno v:
Journal of Clinical Oncology. 29:2312-2318
Purpose Non–small-cell lung cancer (NSCLC) commonly expresses the epidermal growth factor receptor (EGFR), which is associated with poor clinical outcome. Cetuximab is a chimerized monoclonal antibody that targets the EGFR and, in preclinical model
Autor:
Li-An Xu, Thomas J. Lynch, Lowell L. Hart, Christopher T. Harbison, Christine Horak, Robert C. Hermann, Shaker R. Dakhil, Melissa Awad, Shirin Khambata-Ford, Martin R. Weber
Publikováno v:
Journal of Clinical Oncology. 28:918-927
Purpose The anti–epidermal growth factor receptor (EGFR) antibody cetuximab is efficacious in multiple tumor types. Patient selection with markers predictive of benefit may enhance its therapeutic index. This retrospective, correlative analysis of
Autor:
Dennis F. Moore, Primo N. Lara, Zelanna Goldberg, Quynh-Thu Le, John Crowley, James J. Moon, Mary W. Redman, Laurie E. Gaspar, Stephen K. Williamson, David R. Gandara
Publikováno v:
Journal of Clinical Oncology. 27:3014-3019
Purpose A SWOG pilot study (S0004) showed that tirapazamine (TPZ) when combined with concurrent chemoradiotherapy yielded a promising median survival of 22 months in limited-stage small-cell lung cancer (LSCLC). We report results of the phase II stud
Autor:
Julian G. Rosenman, Xiaofei Wang, M. Green, Jeffrey A. Bogart, Everett E. Vokes, Peter Ungaro, Arthur M. Sleeper, Gregory A. Masters, Mark A. Socinski, Antonius A. Miller, Michael T. Munley, Lin Gu, A. William Blackstock
Publikováno v:
Journal of Clinical Oncology. 26:2457-2463
Purpose To evaluate 74 Gy thoracic radiation therapy (TRT) with induction and concurrent chemotherapy in stage IIIA/B non–small-cell lung cancer (NSCLC). Patients and Methods Patients with stage IIIA/B NSCLC were randomly assigned to induction chem
Autor:
Jennifer F. Tseng, Mansoor N. Saleh, Francisco Robert, George R. Blumenschein, Roy S. Herbst, Michael Needle, Frank V. Fossella
Publikováno v:
Journal of Clinical Oncology. 23:9089-9096
PurposeThis multicenter, open-label, phase I/IIa study was undertaken to establish the safety/toxicity profile of cetuximab in combination with gemcitabine and carboplatin in patients with chemotherapy-naïve, epidermal growth factor receptor–posit
Publikováno v:
Journal of Clinical Oncology. 23:6873-6880
Purpose Feasibility and activity of concurrent hyperfractionated radiotherapy (Hfx RT) and low-dose, daily carboplatin and paclitaxel were investigated in patients with early-stage (I/II) non–small-cell lung cancer in a phase II study. Patients and